BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2012
View Archived Issues
New ESC guidelines recommend use of ticagrelor
Read More
Symphogen licenses Sym-004 to Merck KGaA
Read More
FDA continues review of crofelemer NDA beyond PDUFA date
Read More
ValiRx reports data on VAL-201 for breast cancer
Read More
Novel HDAC inhibitors prepared at Dana Farber Cancer Institute
Read More
CSIR patents novel agents for cancer
Read More
Glenmark Pharmaceuticals prepares new MPGES-1 inhibitors
Read More
Novel DGAT1 inhibitors synthesized by Merck & Co.
Read More
Scientists at BioRelix present new flavin derivatives
Read More
Phase II zabofloxacin results presented at ICAAC
Read More
Generon begins clinical studies of IL-22 product
Read More
FG-3019 safe and well tolerated in phase II study in IPF
Read More
Aileron Therapeutics reports on new therapeutic drug program
Read More
NeurOp receives NIH funding for ischemia research
Read More
PM-01183 receives positive opinion for orphan drug status in E.U.
Read More
Sanofi develops new 11-beta-HSD1 inhibitors for the treatment of diabetes
Read More
InSite Vision completes enrollment of DOUBle study
Read More
Janssen makes submissions to the FDA for two different Xarelto sNDAs
Read More
SFJ and Pfizer sign agreement to codevelop treatment for advanced NSCLC
Read More
Atu-111 shows efficacy in preclinical model of acute lung injury
Read More
Phase I/II trial of Astex's HSP 90 inhibitor begins
Read More
Cedars-Sinai Heart Institute receives funding to further study cardiac stem cells
Read More
AstraZeneca discontinues development of candidate in obesity collaboration with Palatin
Read More
Actinium to begin screening patients for second cohort of phase I/II trial in AML
Read More
